Get started
Linical Co., Ltd.Linical Co., Ltd.Linical Co., Ltd.

Linical Co., Ltd.

No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals

Fundamentals and stats

OverviewStatementsStatisticsDividendsEarningsRevenue

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. It operates through the Contract Research Organization (CRO) and Contract Medical Affairs business segments. The CRO business segment provides outsourced pharmaceutical development services. The Contract Medical Affairs business segment handles marketing support on products of the pharmaceutical companies. The company was founded by Kazuhiro Hatano on June 7, 2005 and is headquartered in Osaka, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
2183 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company